Navigation Links
Curemark Enters into Research Collaboration with The Molecular Sciences Institute (VTT/MSI)
Date:8/26/2013

future filing of the company's New Drug Application (NDA) for CM-AT.

About Curemark LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company previously announced that its Phase III double blind randomized placebo controlled multicenter clinical trial of CM-AT for autism met its primary and secondary endpoints. To learn more about the company's innovative science, visit www.curemark.com.

Safe-Harbor Statement

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of the Curemark products CM-AT, CM-4612 and CM-182 their potential advantages, their potential for use in treating diseases or disorders, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning the Curemark products CM-AT, CM-4612 and CM-182. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of the Curemark products CM-AT, CM-4612 and CM-182, our ability to finance our development of CM-AT, CM-4612 and CM-182 regulatory risks, and our reliance on third party researchers and other collaborators. We assume
'/>"/>

SOURCE Curemark LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Curemark Awarded New Patent For Treatment Of Drug And Alcohol Addiction
2. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
3. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
4. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
5. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
6. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
7. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
8. Centers for Medicare & Medicaid Services Win 2012 National Cybersecurity Innovation Award
9. Nu Skin Enterprises Enters Into Agreement To Acquire NOX Technologies
10. Eqalix Enters Sponsored Research Agreement with Temple University
11. BCA Represents Independent Blood Centers at Phacilitate Cell & Gene Therapy Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... SAN DIEGO, Feb. 3 Gen-Probe Incorporated (Nasdaq: ... has joined the Company as senior vice president, research ... expertise and leadership to our already strong senior management ... officer. "We believe Eric will play an integral ...
... Primary and Key Secondary Endpoints -- CAPACITY 1 Misses ... Submit NDA and MAA -BRISBANE, Calif., Feb. 3 ... results from the two Phase 3 CAPACITY studies evaluating ... The primary endpoint of change in percent predicted Forced ...
... is like none other. To mark the observance, African ... promote science education, achievement motivation and positive psychological development among ... ... Washington, DC (PRWEB) February 3, 2009 -- African Ancestry, Inc., ...
Cached Biology Technology:Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development 2InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 2InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 3InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 4InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 5InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 6InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 7InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 8InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 9InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 10InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 11African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test 2African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test 3
(Date:7/9/2014)... Calif. Jason Stajich , an associate professor ... University of California, Riverside, has been awarded the 2014 ... America, a scientific society dedicated to advancing the science ... kinds including mushrooms, molds, truffles, yeasts, lichens, plant pathogens, ... and each year recognizes an outstanding early-career mycologist. Stajich ...
(Date:7/9/2014)... species, selection for traits that are attractive to the ... opportunities to mate, the tail of male peacocks being ... California, Riverside have now found that sexual selection and ... linked. Describing the life histories of more than 150 ... found that species with placentas tend to have males ...
(Date:7/9/2014)... studying critically ill children with traumatic injuries have ... are likely to develop a hospital-acquired infection. The ... and published online in June in the journal ... efforts that could lead to the clinical implementation ... prevent or reverse immune system damage following critical ...
Breaking Biology News(10 mins):UC Riverside plant pathologist receives national recognition 2Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3
... tree ring-based reconstruction of an extinct polar forest,s ... impact of Lake St. Martin bolide on groundwater ... boundary; radar images of volcanic and impact deposits ... into the atmosphere; use of charred plants in ...
... -- The National Academy of Sciences (NAS) will honor ... the areas of biology, chemistry, solar physics, ecology, mathematics, ... awards and recipients for 2008 are: ARCTOWSKI MEDAL ... well as a gift of $60,000 to an institution ...
... Climate Change for the Baltic Sea Basin (BACC), the book ... and possible future climate change in the region, which extends ... mid-Europe. One of the key findings is that air temperatures ... five degrees Celsius from now to 2100. More than 80 ...
Cached Biology News:February Geology and GSA Today media highlights 2February Geology and GSA Today media highlights 3February Geology and GSA Today media highlights 4February Geology and GSA Today media highlights 5February Geology and GSA Today media highlights 6February Geology and GSA Today media highlights 7February Geology and GSA Today media highlights 8February Geology and GSA Today media highlights 9February Geology and GSA Today media highlights 10Academy honors 13 for major contributions to science 2Academy honors 13 for major contributions to science 3Academy honors 13 for major contributions to science 4Academy honors 13 for major contributions to science 5Climate change in the Baltic Sea basin -- past, present and future 2Climate change in the Baltic Sea basin -- past, present and future 3
...
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
... The NEW HandyStep electronic from BRAND ... pipetting. It is the only electronic, ... standard syringe tips, including BRAND PD-Tip ... Plus, Fisherbrand Dispenser Tips,and VWRbrand Combi-Syringes. ...
Biology Products: